Covid-19: US awards $1.6 billion to Novavax for vaccine
WASHINGTON, July 9 (NNN-AGENCIES) — The US announced it was providing $1.6 billion in funding for the development and manufacture of a COVID-19 vaccine candidate produced by biotech firm Novavax, the largest amount awarded under Operation Warp Speed. Separately, the US also said it was providing $450 million to Regeneron…
